NewsPharmaceutical

Global Topical Drug Delivery Market 2024 Size, Analysis, Competitive Strategies and Forecasts, by Top Players:e Allergen Plc. Kaken Pharmaceuticals, Co., Ltd, Pfizer, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc

Some of the prominent trends that the market is witnessing include improved profitability as a result of aim, the introduction of the maintenance-as-a-service model in industries, increasing demand in Industry and growth opportunities and investment opportunities. A Global Topical Drug Delivery Market  overview, competitive analysis, competition from manufacturers, new players, suppliers and vendors, regional output, type and application, volume and shares, sales value and product price, sales revenue and gross margin are some of the important points covered in this report.

Global Topical Drug Delivery Market, By Product Type {Topical (Solid, Liquid, Semi-Solid), Transdermal (Patches, Gels)}; End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others); Distribution Channel (Direct Tenders, Retail); Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024 Global Topical Drug Delivery Market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request Sample Copy Of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market

Points to focus in the report

What was the market size in 2016?

What are the moves of key players?

Which region is leading the market at global level?

A comprehensive/competitive analysis of the market?

Strategies of key players and product offerings

Report Scope

Market drivers and restrains

Key trends of the market

Challenges of market growth

Major players in the market

CAGR values for the forecast period and historic years

For More Information On This Report, Please Visit @ https://databridgemarketresearch.com/press-release/global-topical-drug-delivery-market-3/

Major Topics Covered in this Report:

  1.  Study Coverage
  2.  Executive Summary
  3. Market Size by Manufacturers
  4. Market Size by Type
  5. Market Size by Application
  6. Manufacturers Profiles
  7.  Production Forecasts
  8.  Consumption Forecast
  9. Upstream, Industry Chain and Downstream Customers Analysis
  10.  Opportunities & Challenges, Threat and Affecting Factors
  11.  Key Findings
  12.  Appendix 

For Report TOC Request Here: https://databridgemarketresearch.com/toc/?dbmr=global-chromatography-solvents-market

Report Scope

Market drivers and restrains

Key trends of the market

Challenges of market growth

Major players in the market

CAGR values for the forecast period and historic years

Potential of the report

To gain information about the top players in this industry, their product portfolios, and their key strategies.

Key parameters which are driving this market and restraining its growth

What all challenges manufacturers will face as well as new opportunities and threats faced by them.

Learn about the market strategies that are being adopted by your competitors and leading organizations

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Top Key Players Covered In This Report:

The global topical drug delivery market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Other players in this market include Allergen Plc. Kaken Pharmaceuticals, Co., Ltd, Pfizer, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc., Antares Pharma among others. Some of the other players in the global topical drug delivery market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., and Solvay among others.

Galderma Pharma S.A.

Galderma Pharma S.A. was incorporated in 1981, as a joint between Nestle and L’Oreal. In February, 2014 Nestle SA, entered into an agreement to acquire remaining 50% stake in the company, from L’Oreal S.A. After the completion of the acquisition the company will form the foundation of Nestle Skin Health S.A. Galderma Pharma S.A. is headquartered in Lausanne Switzerland.

Recent Developments:

In July 2016, Galderma announces fda approval of full prescription-strength differin gel for over-the-counter acne use.

In July 2016, Galderma announces approval of epiduo gel for the treatment of acne in Japan.

Bayer AG

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science.

Recent Developments:

On July 2015, the U.S. Food and Drug Administration (FDA) approved Finacea Foam, for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea.

Valeant Pharmaceuticals International, Inc.

Founded in 1994 and headquartered in Quebec, Canada, Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics.

Recent Developments:

  1. In August 2016, Valeant announced the re-launch of its generic ofloxacin otic solution to treat bacterial ear infections. The product was temporarily discontinued in April 2015 due to an issue concerning the active pharmaceutical ingredient supplier, which has been resolved.

To Enquire Regarding This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, South America, MEA, Europe or Asia | Mail us at sopan.gedam@databridgemarketresearch.com

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

 

 

Tags
Show More
Close
Close